Longitudinal analysis of Epstein-Barr virus-associated illness.
Yamashita
Nobuko
N
Department of Pediatrics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. yaman@md.okayama-u.ac.jp
Chayama
Kosuke
K
Miyamura
Takako
T
Wada
Tomoaki
T
Maruyama
Hidehiko
H
Washio
Kana
K
Miyai
Takayuki
T
Morishima
Tsuneo
T
D000914:Antibodies, Viral / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D015139:Blotting, Southern; D016207:Cytokines / Q000097:blood; D004279:DNA, Viral / Q000032:analysis*; D003937:Diagnosis, Differential; D018450:Disease Progression; D020031:Epstein-Barr Virus Infections / Q000097:blood / Q000175:diagnosis / Q000821:virology*; D017809:Fatal Outcome; D005260:Female; D005500:Follow-Up Studies; D004854:Herpesvirus 4, Human / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007223:Infant; D016133:Polymerase Chain Reaction; D014057:Tomography, X-Ray Computed; D019562:Viral Load
D000914:Antibodies, Viral; D000956:Antigens, Viral; D016207:Cytokines; D004279:DNA, Viral; D007074:Immunoglobulin G